Articles tagged "Risk factors"

2020 American Transplant Congress
Characteristics of Early BK Viremia after Renal Transplantation at an Urban Academic Medical Center
K. Kurzweil, K. Lamartina, K. Svaflarska, D. Kutrzuba, N. Fayyaz, O. Piatek, P. West-Thielke, Z. Hajjiri, I. Tzvetanov, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: BK viremia (BKV) is a deleterious complication after renal transplantation that can compromise allograft function. Centers face the challenge of identifying at-risk patients and…
2020 American Transplant Congress
Outcomes Associated with Mycophenolate Weight-Based Dosing in Varying Immunologic Risk Kidney Transplant Recipients
A. A. Al-Bahou, A. R. Webb, M. Bloxam, L. J. Bowman Anger, R. S. Baliga, A. J. Brueckner
Tampa General Hospital, Tampa, FL
*Purpose: Mycophenolate acid (MPA) is traditionally dosed in kidney transplant recipients (KTR) using the FDA-approved fixed dosing which is irrespective of patient-specific variables such as…
2020 American Transplant Congress
Risk Factors for Incisional Hernia Recurrence and Surgical Site Infection in the Transplant Population
O. Andacoglu¹, U. Ozbek², F. Cheema¹, L. Sanchez¹, F. Malcher¹
¹General Surgery, Montefiore Medical Center, Bronx, NY, ²Population Health Science and Policy, Icahn School of Medicine Mount Sinai, New York, NY
*Purpose: To investigate recurrence and surgical site infection (SSI) rates and risk factors after incisional hernia (IH) repair following abdominal transplantation.*Methods: A retrospective review of…
2020 American Transplant Congress
Multi- National Survey among Nephrologists and Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Family History of Kidney Disease
Z. Arabi¹, S. Kaysi², A. Altheaby¹, E. Elhassan¹, M. Bukhari³, A. Mateen¹, A. Hamad⁴
¹KAMC, Riyadh, Saudi Arabia, ²CHR Orleans, Orleans, France, ³Taif University, Taif, Saudi Arabia, ⁴The Regional Medical Center, Orangeburg, SC
*Purpose: Kidney transplantation from a living donor is the best treatment option for End Stage Kidney Disease. Considering the shortage of available organs, transplant centers…
2020 American Transplant Congress
Effects of BMI on Kidney Transplant Outcomes are Highly Modified by Patient and Donor Characteristics
J. Schold¹, J. Augustine², A. Huml², R. Fatica², S. Nurko², A. Wee³, E. Poggio²
¹Cleveland Clinic Foundation, Cleveland, OH, ²Nephrology, Cleveland Clinic Foundation, Cleveland, OH, ³Surgery, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Body Mass Index (BMI) is a well-established risk factor for transplant outcomes and high BMI is a commonly used relative contradiction for used for…
2020 American Transplant Congress
Kidney Transplant from Sickle Cell Donors
P. Vaitla, F. H. Cabeza Rivera, W. Cheungpasitporn, F. Koller, P. Matemavi, J. Wynn
University of Mississippi, Jackson, MS
*Purpose: Patients with End-stage renal disease have an increased risk of death. Dialysis and kidney transplantation are the only treatments. Patients who receive kidney transplantation…
2020 American Transplant Congress
Incidence and Risks Factors of Kidney Allograft Loss Due to BK Virus: UNOS Data Set
H. Patel¹, K. Agrawal¹, A. Pawar¹, N. Leeaphorn², F. Cardarelli¹, N. Agrawal¹
¹Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ²Transplant Nephrology, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO
*Purpose: BK virus infection can lead to graft dysfunction and loss in kidney transplant patients. Incidence and prevalence of BK Viremia (BKV) and BK Virus…
2020 American Transplant Congress
Pulmonary Hypertension is Associated with Inferior Graft and Patient Survival after Kidney Transplantation
M. C. Nguyen, P. Chiang, J. Motter, D. Brennan, A. Massie, J. Garonzik-Wang, D. Segev, D. Segev
Johns Hopkins Hospital, Baltimore, MD
*Purpose: Pulmonary hypertension (PH) is increasingly recognized among patients with chronic kidney disease largely driven by left heart failure, high cardiac output, hypoxic lung diseases…
2020 American Transplant Congress
Pre-Transplant Overt Hepatic Encephalopathy is Associated with Greater Cognitive Improvement after Liver Transplant
M. Kim¹, J. Menzel-Smith¹, J. D. Peipert², K. J. Reid¹, P. Zee¹, D. P. Ladner³
¹Neurology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Surgery, Northwestern University, Chicago, IL
*Purpose: Persistent or residual cognitive impairment following liver transplant is frequently reported yet not well-characterized.*Methods: Cognitive function was tested in a prospective cohort of patients…
2020 American Transplant Congress
Assessing the Complex Causes of Kidney Allograft Loss
E. Van Loon¹, A. Senev¹, E. Lerut², M. Coemans¹, D. Kuypers¹, M. Emonds¹, M. Naesens¹
¹Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, ²KU Leuven, Leuven, Belgium
*Purpose: Although graft loss is a primary endpoint in many studies in kidney transplantation and a broad spectrum of risk factors has been identified, the…